Health Report - Separate stories podcast
Poo transplant shows promise as treatment for peanut allergy
In the news: In a small study, participants with a peanut allergy swallowed capsules containing treated faecal matter, and tried a dose of peanut four months later. Some were able to tolerate the peanut without a reaction. CEO of Eli Lilly discusses barriers to getting their GLP-1 agonist medication listed on the PBS, and questions the veracity of the process for getting the most up to date medications to Australian patients. The President of the United States signed an executive order changing the childhood vaccine schedule, making a link to autism, despite evidence to the contrary. References Nature: First poo transplant to treat food allergy in people has ‘exciting’ results Eli Lilly CEO still wants deal to bring Mounjaro to Australia under PBS Trump signs order to reduce childhood vaccines and break up MMR shots
